A partnership between Nufarm and KingAgroot is trialling FFO as a knockdown herbicide in cropping systems across Australia ...

The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.

Bhubaneswar: The Central Bureau of Investigation (CBI) on Tuesday conducted extensive searches at the official residence of ...

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

IIT Guwahati and K.N. Bioscience partner for C-Phycocyanin production. The collaboration promises cost-effective and ...

Speaking about IIT Guwahati's commitment to developing cutting-edge biotechnologies, Prof. Devendra Jalihal, Director, IIT Guwahati, said, "IIT Guwahati is committed to advancing research that creates ...

Asian equities traded in the US as American depositary receipts were up slightly Tuesday morning, edging 0.12% higher to 2,246.71 on the S&P Asia 50 ADR Index. From North Asia, the gainers were led by ...

In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

Liver cirrhosis treatment market is estimated to reach approximately $15 billion in the U.S. by 2030 Ramat Gan, Israel, Feb.

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ...

Singapore announces a strategic budget to support workers and businesses, addressing rising living costs ahead of elections.

Compugen's innovative approach targets under-explored immune pathways like PVRIG and IL-18 binding protein. Read why I'm ...